VNUS markets a minimally invasive medical device to treat venous disease, including venous reflux and vein valve incompetence. VNUS went public in October 2004. (NASDAQ:VNUS).
Total raised: $1.5M
Investors 2
| Date | Name | Website |
| - | Bay City C... | baycitycap... |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.08.2019 | - | $1.5M | - | biospace.c... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 28.04.2010 | UPDATE: En... | By Brandon Glenn It’s been a ... | - | MedCity Ne... | massdevice... |
| 27.04.2010 | Sinusitis-... | Farley joined VNUS, which deve... | - | - | medcitynew... |
| - | Sinusitis-... | Entellus Medical Inc., which i... | - | - | medcitynew... |